Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant

Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth.

Detalles Bibliográficos
Autores principales: Kurimoto, Tomonori, Shimoji, Yoshikazu, Shimabukuro, Atsuya, Ohshiro, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123542/
https://www.ncbi.nlm.nih.gov/pubmed/34026194
http://dx.doi.org/10.1002/ccr3.4236
_version_ 1783692937771614208
author Kurimoto, Tomonori
Shimoji, Yoshikazu
Shimabukuro, Atsuya
Ohshiro, Tatsuo
author_facet Kurimoto, Tomonori
Shimoji, Yoshikazu
Shimabukuro, Atsuya
Ohshiro, Tatsuo
author_sort Kurimoto, Tomonori
collection PubMed
description Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth.
format Online
Article
Text
id pubmed-8123542
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81235422021-05-21 Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant Kurimoto, Tomonori Shimoji, Yoshikazu Shimabukuro, Atsuya Ohshiro, Tatsuo Clin Case Rep Case Reports Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth. John Wiley and Sons Inc. 2021-05-15 /pmc/articles/PMC8123542/ /pubmed/34026194 http://dx.doi.org/10.1002/ccr3.4236 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Kurimoto, Tomonori
Shimoji, Yoshikazu
Shimabukuro, Atsuya
Ohshiro, Tatsuo
Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
title Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
title_full Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
title_fullStr Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
title_full_unstemmed Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
title_short Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
title_sort recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123542/
https://www.ncbi.nlm.nih.gov/pubmed/34026194
http://dx.doi.org/10.1002/ccr3.4236
work_keys_str_mv AT kurimototomonori recombinanttissuetypeplasminogenactivatortreatmentinanextremelylowbirthweightinfant
AT shimojiyoshikazu recombinanttissuetypeplasminogenactivatortreatmentinanextremelylowbirthweightinfant
AT shimabukuroatsuya recombinanttissuetypeplasminogenactivatortreatmentinanextremelylowbirthweightinfant
AT ohshirotatsuo recombinanttissuetypeplasminogenactivatortreatmentinanextremelylowbirthweightinfant

Ejemplares similares